CAR-T (Shanghai) Biotechnology Co.,Ltd. Report issue

Government Phase 1 Phase 2

Organization Overview

First Clinical Trial
2018
NCT03658655
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CAR-T (Shanghai) Biotechnology Co., Ltd. | CAR-T (Shanghai) Biotechnology Co.,Ltd. | CAR-T (Shanghai) Cell Biotechnology Co., Ltd.